All News - Pharmacy Times
https://www.pharmacytimes.com/news09.02.2022 · View More Allergy Brain Health Breast Cancer Cardiovascular Health Coronavirus Cough and Cold Diabetes Flu Hematology Immunization Infectious Disease Neurology Pain Management Vitamins and Supplements. News. All News. Press Releases. Media. All Videos. Digital Detail. Independent Corner. Insights.
Pharmacy Times
https://www.pharmacytimes.comLatest Clinical News. Bradley J. Monk, MD, FACS, FACOG, leads the discussion on upcoming combination therapy regimens with PARP inhibitors for the treatment of ovarian cancer. But gene therapy may be the next big change; researchers recently identified a calcium modulator that protects the optic nerve in mice.
Pharmacy Times
www.pharmacytimes.com4 hours ago Larotrectinib was the first drug to receive accelerated FDA approval for patients of all ages based on a common molecular marker, independent of tissue origin for targeted therapy. Germline Signature Predicts Adverse Effects With Anti-PD1/PDL1 Checkpoint Therapy
Contact Us - Pharmacy Times
https://www.pharmacytimes.com/contactusContact Us Pharmacy Times 2 Clarke Drive, Suite 100 Cranbury, NJ 08512 Fax: (609) 716-4747 Editorial Colleen Hall Vice President, Content chall@mjhlifesciences.com Davy James Associate Editorial Director djames@pharmacytimes.com Caitlin Mollison Managing Editor cmollison@pharmacytimes.com Alana Hippensteele Senior Editor
Pharmacy Times - Home | Facebook
www.facebook.com › PharmacyTimesPharmacy Times. 1 hr ·. Register today and listen to a panel of experts from Emory Healthcare and Winship Cancer Institute of Emory University discuss topics pertaining to the management of oncology patients by pharmacists within an NCI-designated comprehensive cancer center. Register today: https://bit.ly/3fQ9b3R. Like Comment Share.